{"id":20800,"date":"2026-05-18T12:11:01","date_gmt":"2026-05-18T10:11:01","guid":{"rendered":"https:\/\/www.dopharma.com\/?p=20800"},"modified":"2026-07-07T15:52:33","modified_gmt":"2026-07-07T13:52:33","slug":"dophacyl-avi-new-perspective","status":"publish","type":"post","link":"https:\/\/www.dopharma.com\/en\/technical-support\/dophacyl-avi-new-perspective\/","title":{"rendered":"Dophacyl\u00ae Avi \u2013 new perspective for poultry health and production performance"},"content":{"rendered":"

Have you ever experienced situations in your work where you felt powerless against symptoms such as lameness in birds and reduced weight gain due to Avian Reoviruses infections, subclinical lesions caused by viral diseases like Infectious Bronchitis or Infectious Bursal Disease or other challenges related to bacterial infections, environmental stressors, metabolic disorders etc.?<\/p>\n

If so, there is a more effective way to manage these challenges than you might expect.<\/p>\n

Read more to discover how Dophacyl Avi can help you improve poultry health and achieve measurable performance results.<\/p>\n

Inflammation as the underlying factor<\/strong><\/h3>\n

It doesn\u2019t matter which factors affect your flocks, which you are taking care of, the first reaction on contact with factors affecting bird\u2019s homeostasis is inflammation. All those factors trigger local physiological responses following contact with damaging agents, leading to increased vascular permeability and the release of a range of inflammatory mediators. Over time, chronic or persistent inflammation may result in tissue damage and loss of function.<\/p>\n

Dophacyl<\/strong>\u00a0<\/sup><\/strong>Avi\u00a0\u2013 new standard in anti-inflammatory support for poultry<\/strong><\/h3>\n

To prevent these negative consequences of inflammation in poultry and addressing the needs of veterinarians, Dopharma developed a unique non-steroidal anti-inflammatory drug, taking into account not only anti-inflammatory activity but founding solution for challenging mass application in poultry \u2013 sodium salicylate in Dophacyl Avi.<\/p>\n

Dophacyl Avi is the only product on the market with sodium salicylate. It shows excellent solubility in water compared to all acetylsalicylate-based products, making anti-inflammatory treatment easier and more efficient.<\/p>\n

The inflammation in birds develops much faster than in mammals, particularly in the progression from acute heterophilic inflammation to granuloma formation. Heterophilic inflammation (avian equivalent of neutrophilic inflammation) in birds can evolve into granuloma within one week,<\/strong> driven by rapid macrophage influx attracted by necrotoxins from necrotic lesions. Dophacyl Avi helps to reduce this process by reversibly inhibiting cyclooxygenase activity reducing arachidonic acid conversion to pro-inflammatory prostaglandins. This provides inflammation reduction, pain and fever, limits leukocyte recruitment and modulates inflammatory signaling pathways.<\/p>\n

Support recovery and improve welfare through targeted inflammation control<\/strong><\/h3>\n

When infectious diseases or environmental challenges go beyond your control, do not leave recovery to chance. Take action with Dophacyl Avi as part of your treatment strategy to actively support inflammation control, accelerate recovery in your flock and improve animal welfare.<\/p>\n

Would you like to explore more, how Dophacyl Avi can support different field situations in poultry production?<\/p>\n

Feel free to contact our Technical Support Veterinarian Poultry, Sylwia Doner<\/p>\n

s.doner@dopharma.com<\/a> or ts@dopharma.com<\/a><\/p>\n

M +31 (0)6-11 08 60 03<\/p>\n

\n\n\n\t
\n\t\t\t\t
\n\t\t\t\n\t\t\t\n\n\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\"\"\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n